Crossref journal-article
Springer Science and Business Media LLC
British Journal of Cancer (297)
Authors 7
  1. J J James (first)
  2. A J Evans (additional)
  3. S E Pinder (additional)
  4. E Gutteridge (additional)
  5. K L Cheung (additional)
  6. S Chan (additional)
  7. J F R Robertson (additional)
References 29 Referenced 101
  1. Blanco G, Holli K, Heikkinen M, Kallioniemi O-P, Taskinen P (1990) Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 62: 142–146 (10.1038/bjc.1990.247) / Br J Cancer by G Blanco (1990)
  2. Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114: 637–642 / Surgery by MJ Borst (1993)
  3. Breast Speciality Group of the British Association of Surgical Oncology (1999) The guidelines for the management of metastatic bone diseases in the United Kingdom. Eur J Surg Oncol 25: 3–23 (10.1053/ejso.1998.0593)
  4. Canizares F, Sola J, Perez M, Tovar I, De Las Heras M, Salinas J, Penafiel R, Martinez P (2001) Preoperative values of CA15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis. Tumour Biol 22: 273–281 (10.1159/000050627) / Tumour Biol by F Canizares (2001)
  5. Cheung KL, Evans AJ, Robertson JFR (2001) The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy. Breast Cancer Res Treat 67: 273–278 (10.1023/A:1017909727019) / Breast Cancer Res Treat by KL Cheung (2001)
  6. Cheung KL, Graves CRL, Robertson JFR (2000) Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26: 91–102 (10.1053/ctrv.1999.0151) / Cancer Treat Rev by KL Cheung (2000)
  7. Coleman RE, Rubens RD (1987) The clinical course of bone metastases. Br J Cancer 55: 61–66 (10.1038/bjc.1987.13) / Br J Cancer by RE Coleman (1987)
  8. Coleman RE, Smith P, Rubens RD (1998) Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77: 336–340 (10.1038/bjc.1998.52) / Br J Cancer by RE Coleman (1998)
  9. De la Monte S, Hutchins GM, Moore GW (1988) Influence of age on the metastatic behaviour of breast carcinoma. Hum Pathol 5: 529–534 (10.1016/S0046-8177(88)80199-0) / Hum Pathol by S De la Monte (1988)
  10. Dixon AR, Ellis IO, Elston CW, Blamey RW (1991) A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. Br J Cancer 63: 634–635 (10.1038/bjc.1991.145) / Br J Cancer by AR Dixon (1991)
  11. Ebeling FC, Schmitt UM, Untch M, Nagel D, Fateh-Moghadam A, Stieber P, Seidel D (1999) Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer – univariate and multivariate analysis. Anticancer Res 19: 2545–2550 / Anticancer Res by FC Ebeling (1999)
  12. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20: 479–489 (10.1111/j.1365-2559.1992.tb01032.x) / Histopathology by IO Ellis (1992)
  13. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer: experience from a large study with long term follow up. Histopathology 19: 403–410 (10.1111/j.1365-2559.1991.tb00229.x) / Histopathology by CW Elston (1991)
  14. Fondrinier E, Guerin O, Lorimier G (1997) A comparison of metastatic patterns of invasive ductal and lobular carcinomas of the breast: results of a matched study. Bull Cancer 84: 1101–1107 / Bull Cancer by E Fondrinier (1997)
  15. Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD (2001) Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 91: 17–24 (10.1002/1097-0142(20010101)91:1<17::AID-CNCR3>3.0.CO;2-K) / Cancer by AF Jacobson (2001)
  16. Koenders PG, Beex LVAM, Langens R, Kloppenborg PWC, Smals AGH, Benraad TJ (1991) Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. Breast Cancer Res Treat 18: 27–32 (10.1007/BF01975440) / Breast Cancer Res Treat by PG Koenders (1991)
  17. McLaughlin R, McGrath J, Grimes H, Given HF (2000) The prognostic value of the tumour marker CA 15-3 at initial diagnosis of patients with breast cancer. Int J Biol Markers 15: 340–342 (10.1177/172460080001500412) / Int J Biol Markers by R McLaughlin (2000)
  18. Molina R, Jo J, Fillella X, Zanon G, Pahisa J, Munoz M, Farrus B, Latre ML, Escriche C, Estape J, Ballesta AM (1998) C-erbB-2 oncoprotein, CEA and CA 15.3 in patients with breast cancer: prognostic value. Breast Cancer Res Treat 51: 109–119 (10.1023/A:1005734429304) / Breast Cancer Res Treat by R Molina (1998)
  19. O'Hanlon DM, Kerin MJ, Kent P, Maher D, Grimes H, Given HF (1995) An evaluation of of preoperative CA 15.3 measurement in primary breast carcinoma. Br J Cancer 71: 1288–1291 (10.1038/bjc.1995.249) / Br J Cancer by DM O'Hanlon (1995)
  20. Robertson JFR, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW (1992) Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy. Breast Cancer Res Treat 22: 221–227 (10.1007/BF01840835) / Breast Cancer Res Treat by JFR Robertson (1992)
  21. Robertson JFR, Jaeger W, Syzmendera JJ, Selby C, Coleman R, Howell A, Winstanley J, Jonssen PE, Bombardieri E, Sainsbury JRC, Gronberg H, Kumpulainen E, Blamey RW (1999) The objective measurement of remission and progression in metastatic breast cancer. Eur J Cancer 35: 47–53 (10.1016/S0959-8049(98)00297-4) / Eur J Cancer by JFR Robertson (1999)
  22. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand J-C, Fourquet A, Pouillart P (1996) Infiltrating lobular carcinoma of the breast. Cancer 77: 113–120 (10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8) / Cancer by X Sastre-Garau (1996)
  23. Shering SG, Sherry F, Mc Dermott EW, O Higgins NJ, Duffy MJ (1998) Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma. Cancer 83: 2521–2527 (10.1002/(SICI)1097-0142(19981215)83:12<2521::AID-CNCR17>3.0.CO;2-A) / Cancer by SG Shering (1998)
  24. Solomayer E-F, Diel IJ, Meyberg GC, Gollan C, Baster G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59: 271–278 (10.1023/A:1006308619659) / Breast Cancer Res Treat by E-F Solomayer (2000)
  25. Tampellini M, Berruti A, Gorzegno G, Bitossi R, Bottini A, Durando A, De Matteis A, Farris A, Donadio M, De Fabiani E, Arese P, Sarobba MG, Castiglione F, Moro G, Bonazzi G, Nuzzo F, Massobrio M, Dogliotti L (2001) Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. Tumour Biol 22: 367–373 (10.1159/000050639) / Tumour Biol by M Tampellini (2001)
  26. Williams MR, Todd JH, Ellis IO, Dowle CS, Haybittle JL, Elston CW, Nicholson RI, Griffiths K, Blamey RW (1987) Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer 55: 67–73 (10.1038/bjc.1987.14) / Br J Cancer by MR Williams (1987)
  27. Williams MR, Todd JH, Nicholson RI, Elston CW, Blamey RW, Griffiths K (1986) Survival patterns in hormone treated advanced breast cancer. Br J Surg 73: 752–755 (10.1002/bjs.1800730925) / Br J Surg by MR Williams (1986)
  28. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JFR, Evans AJ (2002) Prognostic factors for patients with hepatic metastases from breast cancer. In preparation (10.1038/sj.bjc.6601038)
  29. Yanick R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and co-morbidity in post menopausal breast cancer patients aged 55 years and older. J Am Med Assoc 285: 885–892 (10.1001/jama.285.7.885) / J Am Med Assoc by R Yanick (2001)
Dates
Type When
Created 22 years ago (Aug. 12, 2003, 2:10 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 8:52 a.m.)
Indexed 1 month, 3 weeks ago (July 5, 2025, 1:21 a.m.)
Issued 22 years ago (Aug. 1, 2003)
Published 22 years ago (Aug. 1, 2003)
Published Online 22 years ago (Aug. 12, 2003)
Published Print 22 years ago (Aug. 1, 2003)
Funders 0

None

@article{James_2003, title={Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features}, volume={89}, ISSN={1532-1827}, url={http://dx.doi.org/10.1038/sj.bjc.6601198}, DOI={10.1038/sj.bjc.6601198}, number={4}, journal={British Journal of Cancer}, publisher={Springer Science and Business Media LLC}, author={James, J J and Evans, A J and Pinder, S E and Gutteridge, E and Cheung, K L and Chan, S and Robertson, J F R}, year={2003}, month=aug, pages={660–665} }